COVID-19 Laptop donations in Spain
Boehringer Ingelheim Spain is donating equipment such as laptops and tablet PCs to support home schooling. Click here to learn more about the support.
Search
COVID-19 USA Double the Impact in the Fight Against COVID-19
Employees can double their impact through the BI Cares Matching Gifts Program. Click here to learn and find out more information about this.
COVID-19: EFPIA Industry Information
The EFPIA and its member companies and associations are committed to the global fight against the coronavirus pandemic. Click here to learn more.
Boosting performance with an inclusive performance culture
Inclusive leaders and an inclusive organisation allow diversity to flourish. Diversity is the mix. Inclusion is making the mix work. Learn more here.
Webinars for clinicians on needs of vulnerable respiratory
Webinars with more than 1,000 HCPs to provide an update on prevention and treatment recommendations for vulnerable respiratory patients. Learn more here.
COVID-19 Volunteering in the U.S.
BI employees across the U.S. are out in their communities making a difference to help improve the lives of those who have been impacted by the coronavirus.
Poultry Innovation Days 2018
As a global leader in poultry disease prevention, Boehringer Ingelheim gathered more than 500 leaders in the global poultry industry in Prague. Learn more.
best-practice-innovative-Corporate-Citizenship-survey
Boehringer Ingelheim is named best practice example for innovative Corporate Citizenship in Germany by CC-survey. Click here to learn more about this.
Production Insights
Boehringer Ingelheim makes an important contribution to the reliable and sustainable supply of pharmaceuticals. Click here to learn and find out more.
1988-2015
Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
Company Video: Value through Innovation
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies. Click here to watch our company video and learn about us.
COVID-19 France Support to Pasteur Institute
As part of our Global Donation Program, we are supporting research on COVID-19 in France. Click here to learn more information about the support.
COVID-19 Jordan medicine donations
Boehringer Ingelheim donates medicines in Jordan to support patients with chronic conditions. Click here to find out more about this support.
Interconnected CRM conditions
Learn about the interconnectivity between the heart, kidney and metabolic systems with this animation featuring the members of the Harold Heart household.
Improving Access to Stroke Care
Boehringer Ingelheim’s Angels Initiative is featured as a Best Practice example by the Access to Medicine Initiative. Click here to find out more.
We are independent, family-owned
At Boehringer Ingelheim we are independent, family-owned and intend to remain so. Click here to discover how we live our Leitbild and learn more.
Purchasing
Find out information about Boehringer Ingelheim's purchasing and supplier relationships here, as well as links to useful resources for suppliers too.
Boehringer Ingelheim & Fighting COVID-19 | Boehringer Ingelheim
Learn how Boehringer Ingelheim may not develop human vaccines but is still part of the medical research collective helping to fight this pandemic.
Boehringer Ingelheim's Board of Managing Directors | Boehringer Ingelheim
Read more about Boehringer Ingelheim's board of managing directors, with information on all five members and their respective responsibilities.
COVID-19 Germany - Sports videos for staying fit at home
Aline Nichtern, Head of the Boehringer Ingelheim Sports Centre, offers an online sports programme for all home office employees. Click here to learn more.
PCI with stenting animation
Atrial fibrillation (AF) is the most common cardiac rhythm disorder worldwide. Click here for more information on Stroke Prevention in atrial fibrillation.
COVID-19 Ivermectin Animal Health Not for Human Use
BI manufactures several veterinary products containing ivermectin. They are not approved or suitable for use in humans to try to prevent or treat COVID-19.
Type 2 Diabetes and Risk of Viral Infections
In the current COVID-19 climate, it’s important for everyone to stay safe at home, particularly people living with conditions such as type-2 diabetes.
The Angels Initiative
The Angels Initiative is a unique healthcare initiative to improve acute care for people who have just suffered a stroke. Click here to learn more.
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalization for heart-failure and cardiovascular death
EMPEROR-Preserved trial reveals that Empagliflozin reduces the risk of hospitalisation for heart-failure and cardiovascular death. Find out more here.